(Total Views: 551)
Posted On: 03/12/2021 10:11:41 PM
Post# of 148905
The FDA historically care only about clinical outcomes, and historically for good reason. So you have a molecule that breaks up Beta Amyloid, great... it doesn't stop progression of Alzheimer's.
RO would be near the bottom of the list, way below statistical significance and clinical significance.
RO would be near the bottom of the list, way below statistical significance and clinical significance.
(1)
(0)Scroll down for more posts ▼
